Cingulate Inc.

NASDAQ (USD): Cingulate Inc. (CING)

Last Price

4.10

Today's Change

0.00 (0.00%)

Day's Change

4.10 - 4.27

Trading Volume

61,130

Overview

Market Cap

13 Million

Shares Outstanding

3 Million

Avg Volume

134,252

Avg Price (50 Days)

4.28

Avg Price (200 Days)

7.21

PE Ratio

-0.09

EPS

-43.22

Earnings Announcement

07-Mar-2025

Previous Close

4.10

Open

4.11

Day's Range

4.1 - 4.27

Year Range

1.8 - 152.4

Trading Volume

60,914

Price Change Highlight

1 Day Change

0.00%

5 Day Change

-4.43%

1 Month Change

-11.83%

3 Month Change

-21.15%

6 Month Change

-41.09%

Ytd Change

-94.92%

1 Year Change

-83.33%

3 Year Change

-99.38%

5 Year Change

-99.62%

10 Year Change

-99.62%

Max Change

-99.62%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment